Study of an experimental weight-loss medication for obesity
Part of Hormones & metabolism clinical trials.
This study tests an experimental medication called SGB-7342 for people who are overweight or obese. The goal is to see if it is safe and helps with weight loss.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your body mass index (BMI) must be between 26.0 and 35.0.
- Your weight must have been stable for the past 3 months.
- You must agree to use effective birth control from signing the form until 6 months after the study ends.
- You must be willing to attend all study visits and follow the study rules.
- You must not have used GLP-1 medications (like Ozempic or Wegovy) in the last 6 months.
- You must not have used other weight-loss drugs in the last 3 months, and your liver function tests must be within normal limits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine (NNC6989-0001) for people who are overweight or have obesity. It checks if the medicine is safe and how the body handles it. If eligible, you would receive the study drug and be monitored closely.
This study tests an experimental drug called IBI3042 in healthy people who are normal weight, overweight, or obese. It is an early-stage trial looking at how safe and tolerable the drug is, and how it affects the body, which could eventually lead to a treatment for weight loss.
This trial tests an experimental medication that may help with weight loss. It aims to see how safe the drug is and how the body responds, possibly leading to a new treatment option for obesity.
This study tests a new medication called IBI3046 for people who are overweight or have obesity. The purpose is to see if it helps with weight loss and works safely.
This study tests a new medicine to see how well it helps people with excess body weight lose weight. It may be an option if you have tried to lose weight through dieting before but haven't had lasting success.
This study tests a new medicine, S1B-509, to see if it helps people with obesity and related health problems lose weight and keep it off over a year. You will be randomly assigned to get S1B-509 or a placebo, and everyone gets lifestyle coaching.
Hear when a new Obesity & Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.